Cargando…
Therapeutic potentials of fasudil in liver fibrosis
Fasudil has the potential to prevent liver fibrosis by activating natural killer cells and inhibiting the proliferation of hepatic stellate cells. Fasudil may be a promising clinical therapeutic drug for the prevention and treatment of liver fibrosis.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661378/ https://www.ncbi.nlm.nih.gov/pubmed/34963748 http://dx.doi.org/10.3748/wjg.v27.i45.7859 |
| _version_ | 1784613356973326336 |
|---|---|
| author | Xi, Yue Xu, Peng-Fei |
| author_facet | Xi, Yue Xu, Peng-Fei |
| author_sort | Xi, Yue |
| collection | PubMed |
| description | Fasudil has the potential to prevent liver fibrosis by activating natural killer cells and inhibiting the proliferation of hepatic stellate cells. Fasudil may be a promising clinical therapeutic drug for the prevention and treatment of liver fibrosis. |
| format | Online Article Text |
| id | pubmed-8661378 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Baishideng Publishing Group Inc |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86613782021-12-27 Therapeutic potentials of fasudil in liver fibrosis Xi, Yue Xu, Peng-Fei World J Gastroenterol Letter to the Editor Fasudil has the potential to prevent liver fibrosis by activating natural killer cells and inhibiting the proliferation of hepatic stellate cells. Fasudil may be a promising clinical therapeutic drug for the prevention and treatment of liver fibrosis. Baishideng Publishing Group Inc 2021-12-07 2021-12-07 /pmc/articles/PMC8661378/ /pubmed/34963748 http://dx.doi.org/10.3748/wjg.v27.i45.7859 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| spellingShingle | Letter to the Editor Xi, Yue Xu, Peng-Fei Therapeutic potentials of fasudil in liver fibrosis |
| title | Therapeutic potentials of fasudil in liver fibrosis |
| title_full | Therapeutic potentials of fasudil in liver fibrosis |
| title_fullStr | Therapeutic potentials of fasudil in liver fibrosis |
| title_full_unstemmed | Therapeutic potentials of fasudil in liver fibrosis |
| title_short | Therapeutic potentials of fasudil in liver fibrosis |
| title_sort | therapeutic potentials of fasudil in liver fibrosis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661378/ https://www.ncbi.nlm.nih.gov/pubmed/34963748 http://dx.doi.org/10.3748/wjg.v27.i45.7859 |
| work_keys_str_mv | AT xiyue therapeuticpotentialsoffasudilinliverfibrosis AT xupengfei therapeuticpotentialsoffasudilinliverfibrosis |